High-quality Immune Assessments
Given the growing number of biologics and immune-targeting drugs, the need to measure and predict the risk of adverse drug reactions in patients is urgent. Animal models fail to address questions related to both safety and effect – resulting in project delays, increased costs, and, above all, a non-optimized clinical program with inherent risks for trial participants.
We combine our strong scientific knowledge with a versatile preclinical platform of circulating human blood – thereby addressing important questions related to the safety and function of biopharmaceuticals.
Not the average CRO
Every drug development project comes with its own needs and challenges. At Immuneed, we design the study together with you and our platform provides an array of readouts within the same experiment. We offer short lead times, a high level of quality, and flexible scientific reports.
We’re happy to answer questions and get you acquainted with Immuneed – contact us today.
We work according to GLP and quality is reflected in everything we do. With ID.Flow's high predictive value, the platform brings you results that are relevant, reliable and reproducible.
We compete not only on the quality and accuracy of data, but also on the speed of achieving it – which is why innovative biotech and agile pharma companies rely on us to ease their transition into the clinic.
We tailor the study design based on your specific needs. You choose the number of read-outs, test substances and the level of reporting: “Brief, Standard or Tailored”.